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Abstract
Both bone marrow (BM) and myocardium contain progenitor cells expressing the c-Kit tyrosine kinase. The aims of this
study were to determine the effects of c-Kit mutations on: i. myocardial c-Kit
+ cells counts and ii. the stability of left
ventricular (LV) contractile function and structure during aging. LV structure and contractile function were evaluated
(echocardiography) in two groups of Kit mutant (W/Wv and W41/W42) and in wild type (WT) mice at 4 and 12 months of
age and the effects of the mutations on LV mass, vascular density and the numbers of proliferating cells were also
determined. In 4 month old Kit mutant and WT mice, LV ejection fractions (EF) and LV fractional shortening rates (FS) were
comparable. At 12 months of age EF and FS were significantly decreased and LV mass was significantly increased only in
W41/W42 mice. Myocardial vascular densities and c-Kit
+ cell numbers were significantly reduced in both mutant groups
when compared to WT hearts. Replacement of mutant BM with WT BM at 4 months of age did not prevent these
abnormalities in either mutant group although they were somewhat attenuated in the W/Wv group. Notably BM
transplantation did not prevent the development of cardiomyopathy in 12 month W41/W42 mice. The data suggest that
decreased numbers and functional capacities of c-Kit
+ cardiac resident progenitor cells may be the basis of the
cardiomyopathy in W41/W42 mice and although defects in mutant BM progenitor cells may prove to be contributory, they
are not causal.
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Introduction
The Kit oncogene (Kit), formerly known as c-Kit or W, codes
for the c-Kit receptor (a tyrosine kinase). Active c-Kit receptors are
essential regulators of hematopoietic stem cell (HSCs) and myeloid
progenitor cell functions [1,2] and are also involved in
melanoblastic and gonadal stem cell functions [3]. Kit mutants
are generally dominant for white spotting, but recessive for severe
effects on hemopoietic precursors and for macrocytic anemia [4].
Anemia is a common manifestation in Kit mutants and it can be
corrected by transplantation of normal bone marrow (BM) into
mutant animals [5–7].
In normal myocardium, cardiac progenitor cells (CPCs) with
functionally competent c-Kit receptors appear to play an
important role in maintaining cardiomyocyte replacement;
moreover, c-Kit
+ progenitor cells of BM derivation may also
be important for the maintenance of cardiac structure and
function [8–14]. Hence, it is possible that functionally significant
mutations of c-Kit receptors in cardiac and/or BM c-Kit
+ cells
might reduce the basal rate of cardiomyocyte replacement
sufficiently to impact myocardial function and structure as
animals age. Hence, we hypothesized that a cardiomyopathy
might develop in c-Kit mutant animals as they aged and we
examined the stability of LV structure and function with
echocardiography over the first year of life (i.e., until ,middle
age) in several groups of mice with Kit mutations (W/Wv and
W41/W42) and in wild type (WT) mice.
We report that adverse changes in LV structure (chamber
dilatation and hypertrophy) and LV function were present in W41/
W42 mice at 12 months of age. These changes were not present in
the hearts of WT or W/Wv mutant groups. Further, replacement of
mutant BM with WT BM (by transplantation post irradiation) did
not prevent the development of cardiomyopathy in W41/W42
mutant mice. These data support the concept that functionally
severe mutations of the c-Kit receptor in CPCs can limit the normal
cardiomyocyte replacement process sufficiently to induce cardio-
myopathy in ‘‘middle aged’’ mice. The data also show that the
presence of normal BM cannot compensate for the presence of Kit
mutant CPCs in the W41/W42 hearts despite the fact that
comparable numbers of normal (i.e. transplanted) BM cells
migrated to the heart in both WT and mutant groups. The current
report is the first to demonstrate a severe cardiomyopathy develops
in W41/W42 Kit mutant mice during the normal aging process.
Methods
Animal model
All experimental procedures were approved by the University of
Minnesota and the Jackson Laboratory (JAX) Animal Resources
Committee.
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To determine if repopulating the mutant bone marrow (BM)
with normal BM could prevent the aging associated decrease in
LV function present in the W41/W42 KIT mutant mice, green
fluorescence protein (GFP) labeled BM cells from C57BL/6-Tg
(UBC-GFP)30Scha/J (Stock number 004353, Jax Lab, USA) were
isolated from femur and tibia, and used as single cell suspensions as
described previously [15,16]. At 4 months of age, recipients were
warmed to dilate tail veins (after irradiation) and twenty million
GFP marked BM cells were injected into the lateral tail veins with
a 30 gauge needle.
Left ventricular functional assessment using
echocardiography
Transthoracic echocardiograms were performed on mice of 4
and 12 months of ages to compare the LV function of Kit mutant
and control mice using a Vevo770 Imaging System (VisualSonics,
Canada) equipped with a RMV 707B transducer (15–45MH)
(VisualSonics Inc, Canada). In addition to conventional two-
dimensional images, M-Mode images of the heart in a parasternal
short axis view were acquired. Eight consecutive measurements
were obtained for left ventricular internal diameters at end-diastole
(LVIDed) and end-systole (LVIDes), using the leading edge
method recommended by the American Society of Echocardiog-
raphy. LV end-diastolic (LVEDV) and end-systolic volumes
(LVESV) were derived. Left ventricular ejection fraction (EF)
and fractional shortening (FS) were calculated as EF%=(L-
VIDed
2-LVIDes
2)/LVIDed
2*100%; and FS%=(LVIDed-
LVIDes)/LVIDed*100%, respectively.
Immunohistochemistry
Mouse hearts were explanted and fixed in 10% formalin, and
then embedded into paraffin and sectioned at 4 mm thickness for
immunohistochemistry study. These heart sections were stained
for c-Kit (R&D System, USA), GFP (Abcam, USA), Ki67 (Abcam,
USA) expression. The c-Kit or GFP positive tissue sections were
counter-stained for the expression of a-sarcomeric actin (a-SA)
(Sigma Aldrich, USA) to visualize the structure of myocardium.
To quantify c-Kit
+ cells in heart, total numbers of c-Kit
+/a-SA
2
cells were counted and data presented as total cells/cm
2.T o
quantify proliferating cardiac cells, total numbers of Ki67
+ nuclei
were counted and data presented as Ki67
+ nuclei/mm
2. The GFP
positive sections were also counter-stained with Ki67 to determine
the contribution of GFP
+ BM to the pool of proliferating cells in
the heart. The percentage of Ki67
+/GFP
+ over GFP
+ cells was
calculated.
Mouse heart sections were dually stained for von Willebrand
factor-8 (vWF-8) (Dako, Denmark) and smooth muscle actin
(Sigma Aldrich, USA) expressions to quantify the vascular density.
Statistical analysis
All data are expressed as mean 6 standard deviation.
Differences among groups were analyzed by one-way ANOVA,
with post hoc comparisons performed using the Bonferroni test. p
values less than 0.05 were considered significant.
Results
Echocardiographic evaluation of LV function
Both left ventricular EF and FS of the mutant and control
groups were similar at 4 months of age (Figure 1). However, in
12 month old W41/W42 mice, EF decreased from 6668% (at 4
months of age) to 4664 at 12 months of age and FS decreased
from 3666t o2 3 62% over the same period (p,0.05 for both).
Moreover, the 12 month values in the W41/W42 mice were not
only significantly lower than those of WT mice (p,0.05), but
also significantly lower than those of the W/Wv mice (p,0.05).
On the other hand, no significant differences in LV function
were found between 12 month old WT and W/Wv groups
(p.0.05).
Cardiac hypertrophy in W41/W42 mutant mice
At 12 months of age, cardiomyocyte size of W41/W42 mice was
significantly increased as compared with that of WT mice
regardless of BM transplantation (Figure 2A–B). Similarly, the
heart weight over body weight (HW/BW, mg/g) index was
increased by 50% in W41/W42 mice as compared with WT
(p,0.05, Figure 2C). Hence, W41/W42 mice had significantly
increased LV mass at 12-month of age resulted from cardiomy-
ocyte hypertrophy.
Reduced myocardial CPCs numbers in all Kit mutant
groups
Typical immuno-staining of myocardial c-Kit
+ cells is illus-
trated in Figure 3A–C. Pronounced reductions of myocardial
CPCs numbers were found in both Kit mutant groups as
compared to the numbers present in WT mice (p,0.01 for both).
WT hearts averaged nearly 58 c-Kit
+ cells per cm
2 but very few
Figure 1. Mouse LV functional studies. (A) ejection fraction, and (B) fractional shortening of mice at both young (4 months) and old (12 months)
age. Only W41/W42 mice showed impaired LV function at 12 months of age. *: p,0.05 vs age-matched WT mice. #:p ,0.05 vs same group at 4
months of age.
doi:10.1371/journal.pone.0033407.g001
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PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33407Figure 2. W41/W42 mutant mice had severe cardiac hypertrophy at 12 months of age. (A) Typical H & E staining pictures of mouse heart
tissue sections. (B) The mean cross sectional area of cardiomyocytes in W41/W42 mice was significantly increased. (C) Heart weight/body weight (HW/
BW) measurements of W41/W42 hearts were also significantly increased. * p,0.05 vs WT mice.
doi:10.1371/journal.pone.0033407.g002
Figure 3. Impaired c-Kit
+ cardiac progenitor cell pool in Kit mutant mice. Shown in panels (A) to (C) are representative immuno-stained
images from hearts of WT, W/Wv, and W41/W42 mice, respectively. Quantification of c-kit
+ cardiac progenitor cells based on immuno-staining images
is shown in panel (D). *: p,0.01 vs WT mice.
doi:10.1371/journal.pone.0033407.g003
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+ cells were found in either the Kit mutant group
(Figure 3D).
BM Transplantation did not increase myocardial CPCs
numbers in W41/W42 mice
We have previously reported that different type of Kit mutant
mice manifested different levels of anemia; importantly, the
anemia in all mutant types tested was corrected by transplan-
tation of normal BM following irradiation of the mutant mice
[1]. This was not surprising because normal BM maintains
hematopoietic functions within the organism and the native BM
in the mutants was incapable of adequately performing this
function.
BM derived c-Kit
+ cells are also thought to migrate to the
myocardium where they can function similarly to CPCs and
participate in cardiac repair [17] and/or activate CPCs (or native
cardiomyocytes) to proliferate and differentiate [18]. Hence, we
asked whether normal BM cells could perform these functions in
the Kit mutant groups. Following BM transplantation, substantial
numbers of GFP labeled cells were found in Kit mutant mouse
hearts (Figure 4). Moreover, BM transplantation induced a
modest, but significant increase of c-Kit
+ cells in myocardium of
W/Wv mice. However, no significant increase of c-Kit
+ cells
occurred in hearts of W41/W42 mice (Figure 5). Cardiac c-Kit
+
cell counts also did not change in WT mice in response to BM
transplantation and the latter remained 10 fold or higher than
those present in the BM transplanted Kit mutants (Figure 5). Thus,
repopulation of W41/W42 mutant with normal (GFP labeled) cells
that migrated from the BM did not increase the numbers of
cardiac c-Kit
+ cells in W41/W42 mice. Hence, the normal BM
cells resident in the heart did not stimulate reproduction of cardiac
c-Kit
+ cells in the presence of the most severe form of the
mutation. Notably, although there was evidence of a tropic effect
of BM derived c-Kit
+ cells on cardiac endogenous c-Kit
+ counts in
the presence of the less severe W/Wv mutation, even after
transplantation these numbers were still markedly lower than those
present in normal hearts (i.e., only about 10% of the normal value)
(Figure 5).
Transplantation of normal BM did not prevent the
development of cardiomyopathy in W41/W42 mice
LV function in hearts of W41/W42 mice at 12 months of age is
illustrated in Figure 1. BM transplantation did not prevent the
reductions of EF and FS or the development of cardiac hypertrophy
inW41/W42 mice at 12 months of age (Figure 1 and 6)
Transplantation of normal BM did not increase
vascularization in hearts of Kit mutant mice
The Kit mutations were associated with significant reductions of
capillary (only vWF-8
+ vessels) density as compared with that of
WT mice even following BM transplantation (Figure 7). Signifi-
cantly lower arteriole (both vWF-8
+ and SMA
+ vessels) density was
also found in Kit mutant mice as compared with WT mice. After
BM transplantation, a significant (unexplained) reduction of
arteriole density was found in WT mice, while arteriolar numbers
were not affected in Kit mutant hearts.
Transplantation of normal BM did not increase cardiac
cell proliferation in hearts of Kit mutant mice
Proliferating cell numbers were similar in W/Wv and WT hearts
(Figure 8), however, significantly reduced in W41/W42 hearts. BM
transplantation did not significantly increase the proliferating
cardiac cell density in WT or mutant hearts. However, proliferating
cell numbers were significantly lower in Kit mutant than WT hearts
with BM transplantation. A few Ki67
+ myocyte nuclei were also
observed in WT hearts (Figure 8A) while they were rarely seen in
Kit mutant hearts. To determine if (migrated) BM cells in the heart
might be proliferating, sections were dually stained for GFP and
Ki67 (Figure9).Itwasfound that 15.464.8%of GFPBMcells were
proliferating in Kit mutant hearts while this value was 21.763.9%
in WT mouse hearts (p.0.05).
Discussion
The major finding in this study was that LV hypertrophy, LV
chamber dilation and decreased LV performance were present in
12 month old W41/W42 but not W/Wv or WT mice of
Figure 4. GFP
+ circulating cells migrate to the hearts of (A) WT, (B) W/Wv and (C) W41/W42 mice. A WT mouse heart without GFP
+ bone
marrow transplantation was shown in panel (D) as a control.
doi:10.1371/journal.pone.0033407.g004
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+ cell counts,
vascularization and proliferation rates of transplanted BM derived
cells in cardiomyopathic W42/W41 hearts were comparable to
those present in normally functioning W/Wv hearts. Importantly,
BM transplantation did not prevent the development of cardio-
myopathy in W41/W42 mice. Taken together, these data support
the hypothesis that the primary cause of the cardiomyopathy in
W41/W42 mice are the decreased numbers and functional
capacities of CPCs and that functionally defective mutant BM
progenitor cells, though possibly contributory to the development
of cardiomyopathy, were not causal factor.
There is a large literature describing the roles played by c-Kit
receptor bearing progenitor cells in tissue maintenance and
regeneration [18–21]. Although much of the reported work has
been concerned with the hematopoietic system, the roles of
resident and/or BM originating c-Kit
+ progenitor cells in normal
cardiomyocyte turnover and regeneration has recently become a
major area of investigation and many reports have suggested that
resident c-Kit
+ cardiac progenitor cells are crucial to these
processes; it has also been suggested that BM derived c-Kit
+
progenitor cells themselves may support myocardial regeneration
[18–21]. Thus functionally significant mutations of c-Kit alleles could
impact physiological cardiomyocyte turnover rates and, therefore,
the maintenance of LV structure and function over the lifespan of
the organism. Further, the effects of a decreased cardiomyocyte
turnover rate might be cumulative and lead to LV abnormalities
later in the life of the organism, the specific time of onset being
dependent on the severity of Kit receptor dysfunction.
In this study, we replaced the BM of WT, W/Wv, and W41/
W42 mice with GFP labeled but otherwise normal BM to
Figure 5. Effects of BM transplantation on c-kit
+ cardiac progenitor cell pool of Kit mutant mice. Shown in panels (A) and (B) are
representative c-kit staining of BM transplanted hearts from W/Wv and W41/W42 mice, respectively. Quantification of c-kit
+ cell pool based on
immuno-staining is shown in panel (C). Bone marrow transplantation did not fully restore the impaired c-Kit
+ cell pool (*: p,0.05 vs WT).
Nevertheless, W/Wv mice (but not W41/W42 mice) modestly increased of c-Kit+ cell numbers in response to BM transplantation (#:p ,0.05 vs W/Wv).
doi:10.1371/journal.pone.0033407.g005
Figure 6. BM transplantation did not prevent LV dysfunction in 12 month old W41/W42 mice. (A) ejection fraction, and (B) fractional
shortening.
doi:10.1371/journal.pone.0033407.g006
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+ BM cells to the heart
was impaired in the mutant hearts, and whether, if this migration
was preserved, it would cause endogenous (mutant) cardiac c-Kit
+
progenitor cells numbers to increase in the mutant groups and,
thereby, prevent the development of abnormalities of LV function
in the 12-month W41/W42 mice. Notably, despite apparently
normal BM cell migratory rates, and mildly increased numbers of
c-Kit
+ progenitor cells in the W/Wv group, c-Kit
+ progenitor cell
numbers were not increased in the W41/42 hearts and LV
abnormalities were not prevented.
Collectively, these findings support several conclusions as
follows. First, the W41/W42 Kit
+ cell mutation is associated with
the development of LV hypertrophy and dysfunction during
normal aging; this finding supports the view that endogenous
cardiac c-Kit
+ cells play an important role in supporting LV
structure and function during normal adult life. Second, the BM
repopulation study showed unimpaired migration of normal BM
originating progenitor cells to the mutant hearts failed to mitigate
the LV abnormalities present in 12 months old W41/W42 hearts.
Consequences of Kit oncogene mutations in cardiac
tissues during the aging process
The human heart contains a small number of progenitor cells
capable of symmetrical and asymmetrical replication [9,22]. A
variety of such progenitor cells have been identified, including cells
expressing Sca-1, c-Kit, islet-1 and side population cells [23–25].
Among these, c-Kit has received much attention. c-kit
+ cardiac
progenitor cells have been shown to be self-renewing, clonogenic,
and multi-potent, and to exhibit biochemical differentiation into
the cardiomyocyte, smooth muscle, and endothelial cell lineages
[26]. Moreover, they have been claimed to induce regeneration of
functional myocardium by their proliferation and differentiation
and/or by activating endogenous cardiac progenitor cells to
proliferate and differentiate. In addition, Kit serves as an
important developmental cue; not only for cardiomyocyte terminal
differentiation but also for regulating the number of cardiac
progenitors in the LV [18].
In the current study, each group of Kit mutant mice had normal
cardiac function at 4 months of age measured by echocardiogra-
phy. However, by 12 months of age, severely impaired LV
function was found in W41/W42 mice. Notably, the hematolog-
ical consequences of W42 mutants are known to be more severe
that those of the other mutant groups. However, the LV
dysfunction probably did not result from the more severe anemia
present in W41/W42 mice because this anemia was corrected by
the transplantation of normal BM as previously reported [5].
Taken together, these data support the concept that fully
functional CPCs are important to the maintenance of normal
LV function during aging.
The issue of why LV hypertrophy is present in the older W41/
42 hearts is also of interest. It might be hypothesized that the
decrease in the rate of cardiomyocyte replacement in that group
somehow increases LV stress. Ki67 staining of cardiac tissue
showed that although proliferating cell densities were similar
between Kit mutant and WT hearts, proliferating cardiomyocytes
were only observed in WT hearts. This suggests that in Kit mutant
mice CPC-based cardiomyocyte regeneration is reduced and may
not be able to match the (required) cardiomyocyte replacement
rate. It is also possible that a reduced rate of proliferation of
already differentiated cardiomyocytes may be contributory. If
present, a reduced cardiomyocyte replacement rate could cause
compensatory LV dilation and result in activation of the cardiac
Figure 7. Dual fluorescent immunostaining for vWF-8 and SMA expression. Representative vascular staining pictures of WT (A&B), W/Wv
(C&D), and W41/W42 (E&F) myocardium. (G) Quantification of blood vessel number based on vWF-8 and SMA staining indicated that mutant hearts
had significantly fewer capillaries and arteioles than did WT mice, BM transplantation did not increase capillary or arteriolar numbers in any group.
*: p,0.05 vs vWF-8 of WT; #:p ,0.0 vs vWF-8 of WT+BM; {:p ,0.05 vs SMA of WT.
doi:10.1371/journal.pone.0033407.g007
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myocyte hypertrophy and dysfunction as well as LV dysfunction
[27].
Transplantation of normal BM fails to rescue LV structure
and function in W41/W42 mice
Transplantation of normal BM into a variety of c-Kit mutant
types has previously been shown to repopulate hematopoietic stem
cell populations and restore populations of red blood cells, etc.
[1,5] As shown in Figure 3, myocardial c-Kit
+ cell numbers are
markedly and comparably decreased in both W/Wv and W41/
W42 hearts. However, in the W/Wv group, transplantation of
normal BM resulted a moderate, but significant, increase in the
level of c-Kit
+ cells in myocardium (to ,10% of WT) while in the
W41/W42 hearts no increase in the total c-Kit
+ cell count was
observed (Figure 5). These data suggest that the modest increase in
the total myocardial c-Kit
+ cell counts observed in the (trans-
planted) W/Wv hearts results from expansion of the pre-existing
resident c-Kit
+ cell pool. This expansion may be a consequence of
paracrine signaling emanating from the transplanted BM cells that
acts on the cardiac endogenous c-Kit
+ cells. Speculatively, the
modest response of the c-Kit
+ cells in the W/Wv hearts might be
interpreted as evidence of superior functional capacity (vs W41/
W42 c-Kit
+ cells) and account for the fact that they did not
develop cardiomyopathy by 12 months of age. Moreover, the lack
of response of the W41/W42 mutant cardiac c-Kit
+ cells to
paracrine signaling from the transplanted BM cells could indicate
lower intrinsic functional capacity than those of their W/Wv
counterparts and supports the hypothesis that lower ‘‘functional’’
capacity facilitated the development of the age dependent
cardiomyopathy. Collectively, these data are compatible with the
concept that resident c-Kit
+ CPCs are most disabled in W41/W42
mutants.
Kit mutant mice had low capillary and arteriole densities in
heart as compared to WT mice and BM transplantation did not
increase capillary and arteriole densities in the mutant hearts. This
suggests that the mutant micro-vasculature progenitor cells of Kit
mutant mice cannot respond to paracrine signaling from the BM
derived cells and further, that normal BM derived cells within the
myocardium cannot themselves trans-differentiate into micro-
vascular cells within the myocardium.
It is also interesting to note that the steady state levels of BM
derived cells within the myocardium were comparable in the
transplanted WT, W/Wv and W41/W42 groups. Hence, the
migratory capacity of the transplanted BM derived cells was
presumably normal in all groups and they may have been equally
Figure 8. Cardiac cell proliferation based on Ki67 staining. Representative Ki67
+ staining pictures of WT (A&B), W/Wv (C&D), and W41/W42
(E&F) hearts without or with BM transplantation. Arrows indicate Ki67
+ nuclei. (G) BM transplantation did not significantly increase Ki67
+ cell numbers
in WT, W/Wv or W41/W42 hearts. *: p,0.05 vs WT, #:p ,0.05 vs WT+BM.
doi:10.1371/journal.pone.0033407.g008
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derived cells themselves, at least in the absence of functional
resident cardiac c-Kit
+ cells, cannot support an adequate rate of
cardiomyocyte turnover. Previously, many groups have reported
that BM derived c-Kit
+ cells play a major role in cardiac
regenerative processes [11] and the current data suggest that this
phenomenon depends on the presence of adequately functioning
CPCs.
Our new findings in W41/W42 mutants suggest that this
combination of c-kit mutant alleles specifically compromises at
least a subset of c-kit functions sufficiently to not only markedly
reduce the size of the cardiac resident c-Kit
+ population but also
their physiological functions as the mice age. The present data are
compatible with the view that the presence of an at least partially
functional c-Kit
+ endogenous cardiac progenitor population is
required for the long term stability of LV structure and function. If
it is assumed that the CPCs function that is most markedly
attenuated in the W41/W42 mutants is the maintenance of the
cardiomyocyte turnover rate, then the present data are in
agreement with the recent findings that heart is not a post mitotic
organ and that some level of cardiomyocyte turnover via cardiac
progenitor cell differentiation does occur during entire life after
birth.
In conclusion, our findings in W41/W42 mutants suggest that
this combination of c-Kit mutant alleles specifically compromises
c-Kit functional capacity sufficiently to: i. markedly reduce the size
of the cardiac resident c-Kit
+ cell population and ii. reduce the
capacity of the cardiac resident c-Kit
+ cell population to support a
normal rate of cardiomyocyte replacement. The primary cause of
the cardiomyopathy in W41/W42 mice is likely the decreased
numbers and functional capacities of cardiac resident c-Kit
+
progenitor cells and not the functional defects mutant BM
progenitor cells. This view is supported by the finding that
repopulation of the W41/W42 mice with normal BM did not
prevent the late development of cardiomyopathy.
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